Sarcoma of vulva, vagina and ovary.
Fiche publication
Date publication
décembre 2011
Journal
Best practice & research. Clinical obstetrics & gynaecology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MERROUCHE Yacine
Tous les auteurs :
Magné N, Pacaut C, Auberdiac P, Jacquin JP, Chargari C, Chauleur C, Haie Meder C, Merrouche Y
Lien Pubmed
Résumé
Less than 5% of vulvar, vaginal and ovarian malignant diseases are sarcomas. Adequate knowledge of these particular malignant diseases is essential for accurate diagnosis and for choice of surgical treatment, adjuvant therapy and efficient medical treatment in relapse. A crucial aspect in the management of women with these diseases is a multidisciplinary approach. Globally, presenting signs and symptoms of these sarcomas are non-specific of histological type but linked to initial location. In view of this, management should be undertaken by clinicians experienced in these particular malignancies. Long-term side-effects, particularly in children with sarcoma, adversely affect quality of life. New treatment strategies require special attention.
Mots clés
Female, Humans, Ovarian Neoplasms, diagnosis, Sarcoma, diagnosis, Vaginal Neoplasms, diagnosis, Vulvar Neoplasms, diagnosis
Référence
Best Pract Res Clin Obstet Gynaecol. 2011 Dec;25(6):797-801